Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-01-08 @ 8:05 AM
Study NCT ID:
NCT04035434
Status:
TERMINATED
Last Update Posted:
2025-10-24
First Post:
2019-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
Sponsor:
CRISPR Therapeutics AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-22
First Submit QC Date:
None
Study First Post Date:
2019-07-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-08
Results First Submit QC Date:
None
Results First Post Date:
2025-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-09
Last Update Post Date:
2025-10-24
Last Update Post Date Type:
ESTIMATED